Literature DB >> 19483052

Rituximab therapy in autoimmune pulmonary alveolar proteinosis.

R Borie1, M-P Debray, C Laine, M Aubier, B Crestani.   

Abstract

Idiopathic pulmonary alveolar proteinosis is presumed to be an autoimmune disorder that may lead to pulmonary insufficiency. However, steroids do not appear to be effective and the standard of therapy is whole-lung lavage. We report the first case of successful therapy with rituximab, which addresses the pathogenic mechanism of pulmonary alveolar proteinosis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19483052     DOI： 10.1183/09031936.00160908

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


  27 in total

1.  Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

Authors:  Sarah K Browne; Rifat Zaman; Elizabeth P Sampaio; Kamonwan Jutivorakool; Lindsey B Rosen; Li Ding; Minjal J Pancholi; Lauren M Yang; Debra Long Priel; Gulbu Uzel; Alexandra F Freeman; Carlton E Hayes; Roger Baxter; Stuart H Cohen; Steven M Holland
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

2.  Determination of human anticytokine autoantibody profiles using a particle-based approach.

Authors:  Li Ding; Allen Mo; Kamonwan Jutivorakool; Minjal Pancholi; Steven M Holland; Sarah K Browne
Journal:  J Clin Immunol       Date:  2011-12-06       Impact factor: 8.317

Review 3.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

4.  Anti-cytokine autoantibodies explain some chronic mucocutaneous candidiasis.

Authors:  Sarah K Browne; Steven M Holland
Journal:  Immunol Cell Biol       Date:  2010-06-15       Impact factor: 5.126

5.  Pulmonary alveolar proteinosis as an unusual pattern of lung involvement in Sjögren syndrome.

Authors:  Eugene Park; Hae-Rim Kim; Hee Joung Kim; Sang-Heon Lee
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

Review 6.  Pulmonary alveolar proteinosis: report of two cases in the West of Ireland with review of current literature.

Authors:  M J McDonnell; C Reynolds; V Tormey; J J Gilmartin; R M Rutherford
Journal:  Ir J Med Sci       Date:  2013-06-08       Impact factor: 1.568

Review 7.  Immunodeficiency secondary to anticytokine autoantibodies.

Authors:  Sarah K Browne; Steven M Holland
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-12

8.  Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients.

Authors:  Jianmin Xue; Daniel J Kass; Jessica Bon; Louis Vuga; Jiangning Tan; Eva Csizmadia; Leo Otterbein; Makoto Soejima; Marc C Levesque; Kevin F Gibson; Naftali Kaminski; Joseph M Pilewski; Michael Donahoe; Frank C Sciurba; Steven R Duncan
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

9.  Protein microarrays identify disease-specific anti-cytokine autoantibody profiles in the landscape of immunodeficiency.

Authors:  Jacob M Rosenberg; Jordan V Price; Gabriela Barcenas-Morales; Lourdes Ceron-Gutierrez; Sophie Davies; Dinakantha S Kumararatne; Rainer Döffinger; Paul J Utz
Journal:  J Allergy Clin Immunol       Date:  2015-09-11       Impact factor: 10.793

10.  Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis.

Authors:  Lindsey B Rosen; Alexandra F Freeman; Lauren M Yang; Kamonwan Jutivorakool; Kenneth N Olivier; Nasikarn Angkasekwinai; Yupin Suputtamongkol; John E Bennett; Vasilios Pyrgos; Peter R Williamson; Li Ding; Steven M Holland; Sarah K Browne
Journal:  J Immunol       Date:  2013-03-18       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.